Probiotics for vulvovaginal candidiasis in non-pregnant women
Xie HY, Feng D, Wei DM
Published in Cochrane Database of Systematic Reviews
Methodology
Cochrane review of 10 RCTs of probiotics as adjunct to conventional antifungal treatment for vulvovaginal candidiasis.
Key Findings
Probiotics as adjuncts may increase short-term clinical and mycological cure and lower one-month relapse, but all evidence was low or very low certainty.
Conclusions
Probiotics are a plausible adjunct to antifungals, not a standalone treatment for candida overgrowth.
Limitations
Low certainty; heterogeneous strains and routes; short follow-up.
Supplements Studied
Probiotics as adjuncts to antifungals may improve short-term cure and reduce one-month relapse of candidiasis.
Probiotic adjuncts, including yeast and lactobacillus preparations, showed low-certainty benefit in candidiasis.
Outcomes Measured
Probiotic adjuncts improved short-term mycological cure in vulvovaginal candidiasis.
There is insufficient high-quality evidence to support the use of probiotics for vulvovaginal candidiasis in non-pregnant women.
To assess the effectiveness and safety of probiotics for the treatment of vulvovaginal candidiasis in non-pregnant women.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.